2012
DOI: 10.2215/cjn.02320312
|View full text |Cite
|
Sign up to set email alerts
|

Adenine Phosphoribosyltransferase Deficiency

Abstract: SummaryComplete adenine phosphoribosyltransferase (APRT) deficiency is a rare inherited metabolic disorder that leads to the formation and hyperexcretion of 2,8-dihydroxyadenine (DHA) into urine. The low solubility of DHA results in precipitation of this compound and the formation of urinary crystals and stones. The disease can present as recurrent urolithiasis or nephropathy secondary to crystal precipitation into renal parenchyma (DHA nephropathy). The diagnostic tools available-including stone analysis, cry… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
106
0
4

Year Published

2014
2014
2023
2023

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 96 publications
(111 citation statements)
references
References 42 publications
1
106
0
4
Order By: Relevance
“…High doses of adenine, however, result in toxicity and pathology associated with the xanthine oxidase-mediated conversion of adenine to the insoluble 2,8 dihydroxyadenine, which forms crystals, primarily in the kidney. This occurs in APRT deficiency, but can be managed via the use of the xanthine oxidase inhibitor, allopurinol [108]. Given this concern, the introduction of adenine as a component of blood transfusion products was delayed in some countries until extensive animal and human studies established safe limits for intravenous infusion, which are in the region of 10-15 mg/kg [109].…”
Section: Safety and Tolerabilitymentioning
confidence: 99%
“…High doses of adenine, however, result in toxicity and pathology associated with the xanthine oxidase-mediated conversion of adenine to the insoluble 2,8 dihydroxyadenine, which forms crystals, primarily in the kidney. This occurs in APRT deficiency, but can be managed via the use of the xanthine oxidase inhibitor, allopurinol [108]. Given this concern, the introduction of adenine as a component of blood transfusion products was delayed in some countries until extensive animal and human studies established safe limits for intravenous infusion, which are in the region of 10-15 mg/kg [109].…”
Section: Safety and Tolerabilitymentioning
confidence: 99%
“…Infrared spectroscopy allows correct identification. 3,4 By light microscopy, crystals may resemble calcium oxalate; however, they appear brown on the hematoxylin and eosin stain, whereas calcium oxalate crystals are optically clear. 4,6 DHA crystals reflect light in polarized or phase-contrast microscopy (Figures 2 and 3).…”
Section: Discussionmentioning
confidence: 99%
“…Crystals may lack the typical features of DHA. 3,4 Clinical presentation can be AKI, CKD, or acute allograft dysfunction in patients with no previous stone history. 4 Most cases have been reported from Iceland, Japan, and France.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations